Close Menu

NEW YORK (360Dx) – Barclays today initiated coverage of Abbott Laboratories with an Overweight rating for its stock and a target price of $80 per share. It also initiated coverage of Becton Dickinson with an Equal Weight rating and stock price target of $278.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.